MASTL regulates EGFR signaling to impact pancreatic cancer progression
- 30 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (38), 5691-5704
- https://doi.org/10.1038/s41388-021-01951-x
Abstract
Pancreatic cancer (PC) remains a major cause of cancer-related deaths primarily due to its inherent potential of therapy resistance. Checkpoint inhibitors have emerged as promising anti-cancer agents when used in combination with conventional anti-cancer therapies. Recent studies have highlighted a critical role of the Greatwall kinase (microtubule-associated serine/threonine-protein kinase-like (MASTL)) in promoting oncogenic malignancy and resistance to anti-cancer therapies; however, its role in PC remains unknown. Based on a comprehensive investigation involving PC patient samples, murine models of PC progression (Kras;PdxCre-KC and Kras;p53;PdxCre-KPC), and loss and gain of function studies, we report a previously undescribed critical role of MASTL in promoting cancer malignancy and therapy resistance. Mechanistically, MASTL promotes PC by modulating the epidermal growth factor receptor protein stability and, thereupon, kinase signaling. We further demonstrate that combinatorial therapy targeting MASTL promotes the efficacy of the cell-killing effects of Gemcitabine using both genetic and pharmacological inhibitions. Taken together, this study identifies a key role of MASTL in promoting PC progression and its utility as a novel target in promoting sensitivity to the anti-PC therapies.This publication has 61 references indexed in Scilit:
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and TherapyPLOS ONE, 2013
- Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axisThe EMBO Journal, 2013
- Pancreatic cancer: why is it so hard to treat?Therapeutic Advances in Gastroenterology, 2013
- Galectin-3 Regulates Intracellular Trafficking of EGFR through Alix and Promotes Keratinocyte MigrationJournal of Investigative Dermatology, 2012
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Stable Government of Mitosis by Greatwall: the Emperor's Best ServantMolecular and Cellular Biology, 2012
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial CellsOnline Journal of Public Health Informatics, 2011
- Epidermal Growth Factor Receptor in Pancreatic CancerCancers, 2011
- The M Phase Kinase Greatwall (Gwl) Promotes Inactivation of PP2A/B55δ, a Phosphatase Directed Against CDK PhosphositesMolecular Biology of the Cell, 2009
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006